Nova Patents
AT478944T

Cytokine (zcytor17 ligand)

Abstract

The invention relates to zcytor171ig polynucleotide and a polypeptide and Resist-zcytor17 antibody molecule. The zcytor171ig is a novel cell factor. The polypeptide can be used for increasing hours system, and hematopoietic cells and the inner proliferation and/and method for growing. The invention further comprises a wherein said protein, wherein the method and application antibody.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

135 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
35032502United States of AmericaP
37532302United States of AmericaP
43531502United States of AmericaP

Members135

Family members, oldest first
DocumentOfficeKind
CA2473686A1CanadaA1
WO03060090A2World Intellectual Property Organization (WIPO)A2
AU2003225525A1AustraliaA1
US2003215838A1United States of AmericaA1
US2003224487A1United States of AmericaA1
CA2473733A1CanadaA1
WO2004003140A2World Intellectual Property Organization (WIPO)A2
AU2003280410A1AustraliaA1
WO03060090A3World Intellectual Property Organization (WIPO)A3
KR20040082394ARepublic of KoreaA
NO20043419LNorwayL
EP1476541A2European Patent Office (EPO)A2
BR0306979ABrazilA
ZA200405695BSouth AfricaB
RU2004125165ARussian FederationA
PL371586A1PolandA1
CN1643138AChinaA
WO2004003140A3World Intellectual Property Organization (WIPO)A3
JP2005526494AJapanA
EP1576112A2European Patent Office (EPO)A2
EP1476541A4European Patent Office (EPO)A4
JP2006500919AJapanA
US7064186B2United States of AmericaB2
US2006141579A1United States of AmericaA1
US2007048222A1United States of AmericaA1
US2007048223A1United States of AmericaA1
US2007048831A1United States of AmericaA1
US2007048832A1United States of AmericaA1
US2007048833A1United States of AmericaA1
US2007048834A1United States of AmericaA1
US2007048835A1United States of AmericaA1
US2007049530A1United States of AmericaA1
US2007077627A1United States of AmericaA1
US2007111266A1United States of AmericaA1
US2007140963A1United States of AmericaA1
US2007140964A1United States of AmericaA1
EP1576112A4European Patent Office (EPO)A4
US2007249020A1United States of AmericaA1
EP1476541B1European Patent Office (EPO)B1
AU2003225525B2AustraliaB2
AT401390TAustriaT
ATE401390T1AustriaT1
EP1961811A1European Patent Office (EPO)A1
DE60322188D1GermanyD1
US7425325B2United States of AmericaB2
DK1476541T3DenmarkT3
AU2008230054A1AustraliaA1
US7459293B2United States of AmericaB2
ES2310660T3SpainT3
US7494804B2United States of AmericaB2
US7507795B2United States of AmericaB2
AU2003280410B2AustraliaB2
AU2003280410B8AustraliaB8
US7531636B2United States of AmericaB2
US2009149635A1United States of AmericaA1
RU2360923C2Russian FederationC2
US2009192292A1United States of AmericaA1
US2009274694A1United States of AmericaA1
RU2008118223ARussian FederationA
RU2008118225ARussian FederationA
RU2008118227ARussian FederationA
CN100575482CChinaC
JP2010043120AJapanA
US2010055101A1United States of AmericaA1
US7740834B2United States of AmericaB2
JP4511349B2JapanB2
EP1961811B1European Patent Office (EPO)B1
AT478944TThis recordAustriaT
ATE478944T1AustriaT1
EP2230299A1European Patent Office (EPO)A1
CN101843895AChinaA
DE60333963D1GermanyD1
US2010266499A1United States of AmericaA1
US2010266597A1United States of AmericaA1
DK1961811T3DenmarkT3
ES2351678T3SpainT3
KR101013401B1Republic of KoreaB1
IL210454A0IsraelA0
IL210455A0IsraelA0
EP2338910A1European Patent Office (EPO)A1
US2011196128A1United States of AmericaA1
IL163066AIsraelA
US8013124B2United States of AmericaB2
CA2473686CCanadaC
JP4795641B2JapanB2
EP2230299B1European Patent Office (EPO)B1
AT536406TAustriaT
ATE536406T1AustriaT1
US2011318354A1United States of AmericaA1
AU2008230054B2AustraliaB2
US8124378B2United States of AmericaB2
EP1576112B1European Patent Office (EPO)B1
PT2230299EPortugalE
AT547430TAustriaT
ATE547430T1AustriaT1
ES2377188T3SpainT3
DK2230299T3DenmarkT3
AU2012202219A1AustraliaA1
PT1576112EPortugalE
ES2382800T3SpainT3
Showing 100 of 135